Nongenomic Route of Action of TCDD: Identity, Characteristics, and Toxicological Significance

The AH Receptor in Biology and Toxicology

Volumn , Issue , 2011, Pages 197-215

  Matsumura, Fumio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

"nongenomic signaling" cancer promoter; Ligand activated AHR, "stress response"; TCDD nongenomic, toxicology

Indexed keywords

EID: 84862245261     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118140574.ch13     Document Type: Chapter

References (91)

1. McMillan, B. J. and Bradfield, C. A. (2007). The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Molecular Pharmacology, 72, 487-498.
2. Delescluse, C., Lemaire, G., de Sousa, G., and Rahmani, R. (2000). Is CYP1A1 induction always related to AHR signaling pathway? Toxicology, 153, 73-82.
3. Weiss, U. (2008). Inflammation. Nature, 454, 427.
4. Stellato, C. (2004). Post-transcriptional and nongenomic effects of glucocorticoids. Proceedings of American Thoracic Society, 1, 255-263.
5. Burgermeister, E. and Seger, R. (2007). MAPK kinases as nucleo-cytoplasmic shuttles for PPARg. Cell Cycle, 6, 1539-1548.
6. Stice, J. P. and Knowlton, A. A. (2008). Estrogen, NF-kB, and the heat shock response. Molecular Medicine, 14, 517-527.
7. Cancela, L., Nemere, I., and Norman, A. W. (1988). 1α,25 (OH)2 vitamin D3: a steroid hormone capable of producing pleiotropic receptor-mediated biological responses by both genomic and nongenomic mechanisms. Journal of Steroid Biochemistry, 30, 33-9.
8. Vasudevan, N. and Pfaff, D. W. (2007). Membrane-initiated actions of estrogens in neuroendocrinology: emerging principles. Endocrine Reviews, 28, 1-19.
9. Lange, C. A. (2004). Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word? Molecular Endocrinology, 18, 269-278.
10. Freeman, M. R., Cinar, B., and Lu, M. L. (2005). Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer. Trends in Endocrinology and Metabolism, 16, 273-279.
11. Carlson, D. B. and Perdew, G. H. (2002).Adynamic role for the Ah receptor in cell signaling? Insights from a diverse group of Ah receptor interacting proteins. Journal of Biochemical and Molecular Toxicology, 16, 317-325.
12. Boutwell, R. K., Takigawa, M., Verma, A. K., and Ashendel, C. L. (1983). Observations on the mechanism of skin tumor promotion by phorbol esters. Princess Takamatsu Symposium, 14, 177-193.
13. Hecker, E. (1985). Cell membrane associated protein kinase C as receptor of diterpene ester co-carcinogens of the tumor promoter type and the phenotypic expression of tumors. Arzneimittelforschung, 35, 1890-1903.
14. Bell, R. M., Hannun, Y. A., and Loomis, C. R. (1986). Mechanism of regulation of protein kinase C by lipid second messengers. Symposium on Fundamental Cancer Research, 39, 145-156.
15. Das, U. N. (1991). Arachidonic acid as a mediator of some of the actions of phorbolmyristate acetate, a tumor promoter and inducer of differentiation. Prostaglandins Leukotrienes and Essential Fatty Acids, 42, 241-244.
16. Haffner, S.M. (2000). Clinical relevance of the oxidative stress concept. Metabolism, 49, 30-34.
17. Kundu, J. K., Shin, Y. K., and Surh, Y. J. (2006). Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kB and AP-1 as prime targets. Biochemical Pharmacology, 72, 1506-1515.
18. Garg, R., Ramchandani, A. G., and Maru, G. B. (2008). Curcumin decreases 12-O-tetradecanoylphorbol-13-acetateinduced protein kinaseCtranslocation to modulate downstream targets in mouse skin. Carcinogenesis, 29, 1249-1257.
19. Cossins, A., Fraser, J., Hughes, M., and Gracey,A. (2006). Postgenomic approaches to understanding the mechanisms of environmentally induced phenotypic plasticity. Journal of Experimental Biology, 209, 2328-2336.
20. Osterloh, A. and Breloer, M. (2008). Heat shock proteins: linking danger and pathogen recognition. Medical Microbiology and Immunology, 197, 1-8.
21. Barton, G. M. (2008). A calculated response: control of inflammation by the innate immune system. Journal of Clinical Investigation, 118, 413-420.
22. Mazina, O., Park, S., Sano, H., Wong, P., and Matsumura, F. (2004). Studies on the mechanism of rapid activation of protein tyrosine phosphorylation activities, particularly c-Src kinase, by TCDD in MCF10A. Journal of Biochemical and Molecular Toxicology, 18, 313-321.
23. Park, S., Mazina, O., Kitagawa, A., Wong, P., and Matsumura, F. (2004). TCDD causes suppression of growth and differentiation of MCF10A, human mammary epithelial cells by interfering with their insulin receptor signaling through c-Src kinase and ERK activation. Journal of Biochemical and Molecular Toxicology, 18, 322-331.
24. Park, S. and Matsumura, F. (2006). Characterization of antiapoptotic action of TCDD as a defensive cellular stress response reaction against the cell damaging action of ultra-violet irradiation in an immortalized normal human mammary epithelial cell line, MCF10A. Toxicology, 217, 139-146.
25. Dong, B. and Matsumura, F. (2008). Roles of cytosolic phospholipase A2 and Src kinase in the early action of 2,3,7,8-tetrachlorodibenzo-p-dioxin through a nongenomic pathway in MCF10A cells. Molecular Pharmacology, 74, 255-263.
26. Dong, B and Matsumura, F. (2009). The conversion of rapid TCCD nongenomic signals to persistent inflammatory effects via select protein kinases in MCF10A cells. Molecular Endocrinology, 23, 549-558.
27. Puga, A., Nebert, D.W., and Carrier, F. (1992). Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA and Cell Biology, 11, 269-281.
28. Matsumura, F., Brewster, D. W., Madhukar, B. V., and Bombick, D.W. (1984). Alteration of rat hepatic plasma membrane functions by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Archives of Environmental Contamination and Toxicology, 13, 509-515.
29. Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature, 454, 428-435.
30. Sciullo, E. M., Vogel, C. F., Li, W., and Matsumura, F. (2008). Initial and extended inflammatory messages of the nongenomic signaling pathway of the TCDD-activated Ah receptor in U937 macrophages. Archives of Biochemistry and Biophysics, 480, 143-155.
31. Li, W. and Matsumura, F. (2008). Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3T3-L1 adipocytes. Biochemistry, 47, 13997-14008.
32. Li, W., Vogel, C. F., Fujiyoshi, P., and Matsumura, F. (2008). Development of a human adipocyte model derived from human mesenchymal stem cells (hMSC) as a tool for toxicological studies on the action of TCDD. Biological Chemistry, 389, 169-177.
33. Dong, B., Nishimura, N., Vogel, C. F., Tohyama, C., and Matsumura, F. (2010). TCDD-induced cyclooxygenase-2 expression is mediated by the nongenomic pathway in mouse MMDD1 macula densa cells and kidneys. Biochemical Pharmacology, 79, 487-497.
34. Bombick, D. W., Madhukar, B. V., Brewster, D. W., and Matsumura, F. (1985). TCDD (2,3,7,8-tetrachlorodibenzo-pdioxin) causes increases in protein kinases particularly protein kinase C in the hepatic plasma membrane of the rat and the guinea pig. Biochemical and Biophysical Research Communications, 127, 296-302.
35. Bombick, D.W. and Matsumura, F. (1987). 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes elevation of the levels of the protein tyrosine kinase pp60c-src. Journal of Biochemical Toxicology, 2, 141-154.
36. Madhukar, B. V., Ebner, K., Matsumura, F., Bombick, D. W., Brewster D. W., and Kawamoto, T. (1988). 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an increase in protein kinases associated with epidermal growth factor receptor in the hepatic plasma membrane. Journal of Biochemical Toxicology, 3, 261-277.
37. Sewall, C. H., Lucier, G.W., Tritscher, A. M., and Clark, G. C. (1993). TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenic action of TCDD. Carcinogenesis, 14, 1885-1893.
38. Kohn, M. C. and Portier, C. J. (1994). A model of effects of TCDD on expression of rat liver proteins. Progress in Clinical Biology Research, 387, 211-222.
39. Abbott, B. D. and Birnbaum, L. S. (1990). TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicology and Applied Pharmacology, 106, 418-432.
40. Abbott, B. D., Buckalew, A. R., and Leffler, K. E. (2005). Effects of epidermal growth factor (EGF), transforming growth factor-alpha (TGFa), and 2,3,7,8-tetrachlorodibenzo-p-dioxin on fusion of embryonic palates in serum-free organ culture using wild-type, EGF knockout, and TGFa knockout mouse strains. Birth Defects Research, Part A, 73, 447-454.
41. Matsumura, F. (1994). How important is the protein phosphorylation pathway in the toxic expression of dioxin-type chemicals? Biochemical Pharmacology, 48, 215-224.
42. Kitamura, N., Wong, P., and Matsumura, F. (2006). Mechanistic investigation on the cause for reduced toxicity of TCDD in wa-1 homozygous TGFa mutant strain of mice as compared its matching wild-type counterpart, C57BL/6J mice. Journal of Biochemical and Molecular Toxicology, 20, 151-158.
43. Kohle, C., Gschaidmeier, H., Lauth, D., Topell, S., Zitzer, H., and Bock, K. W. (1999). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-mediated membrane translocation of c-Src protein kinase in liver WB-F344 cells. Archives of Toxicology, 73, 152-158.
44. Haarmann-Stemmann, T., Bothe, H., and Abel, J. (2009). Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AHR) signaling pathways. Biochemical Pharmacology, 77, 508-520.
45. Bombick, D. W., Jankun, J., Tullis, K., and Matsumura, F. (1988). 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains. Proceedings of the National Academy of Sciences of the United States of America, 85, 4128-4132.
46. Bagchi, D., Bagchi, M., Tang, L., and Stohs, S. J. (1997). Comparative in vitro and in vivo protein kinase C activation by selected pesticides and transition metal salts. Toxicology Letters, 91, 31-37.
47. Weber, T. J., Chapkin, R. S., Davidson, L. A., and Ramos, K. S. (1996). Modulation of protein kinase C-related signal transduction by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits cell cycle dependence. Archives of Biochemistry and Biophysics, 328, 227-232.
48. Williams, S. R., Son, D. S., and Terranova, P. F. (2004). Protein kinase C delta is activated in mouse ovarian surface epithelial cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicology, 195, 1-17.
49. Kim, S. Y., Lee, H. G., Choi, E. J., Park, K. Y., and Yang, J. H. (2007). TCDD alters PKC signaling pathways in developing neuronal cells in culture. Chemosphere, 67, S421-S427.
50. Wolfle, D., Schmutte, C., and Marquardt, H. (1993). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on protein kinase C and inositol phosphate metabolism in primary cultures of rat hepatocytes. Carcinogenesis, 14, 2283-2287.
51. Rich, T. C. and Karpen, J. W. (2002). Review article: cyclic AMP sensors in living cells: what signals can they actually measure? Annals of Biomedical Engineering, 30, 1088-1099.
52. Matsumura, F. (2009). The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxinactivated Ah receptor to cause toxic effects. Biochemical Pharmacology, 77, 608-626.
53. Vogel, C. F., Sciullo, E., Park, S., Liedtke, C., Trautwein, C., and Matsumura, F. (2004). Dioxin increases C/EBPb transcription by activating cAMP/protein kinase A. Journal of Biological Chemistry, 279, 8886-8894.
54. McKenzie, K. E., Bandyopadhyay, G. K., Imagawa, W., Sun, K., and Nandi, S. (1994). Omega-3 and omega-6 fatty acids and PGE2 stimulate the growth of normal but not tumor mouse mammary epithelial cells: evidence for alterations in the signaling pathways in tumor cells. Prostaglandins Leukotrienes and Essential Fatty Acids, 51, 437-443.
55. Oesch-Bartlomowicz, B. and Oesch, F. (2009). Role of cAMP in mediating AHR signaling. Biochemical Pharmacology, 77, 627-641.
56. de Oliveira, S. K., Hoffmeister, M., Gambaryan, S., Muller-Esterl, W., Guimaraes, J. A., and Smolenski, A. P. (2007). Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. Journal of Biological Chemistry, 282, 13656-13663.
57. Filhol, O. and Cochet, C. (2000). Protein kinase CK2 in health and disease: cellular functions of protein kinase CK2: a dynamic affair. Cell and Molecular Life Science, 66, 1830-1839.
58. Enan, E. and Matsumura, F. (1995). Regulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of the DNA binding activity of transcriptional factors via nuclear protein phosphorylation in guinea pig adipose tissue. Biochemical Pharmacology, 50, 1199-1206.
59. Ashida, H., Nagy, S., and Matsumura, F. (2000). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced changes in activities of nuclear protein kinases and phosphatases affecting DNA binding activity of c-Myc and AP-1 in the livers of guinea pigs. Biochemical Pharmacology, 59, 741-751.
60. Singh, N. N. and Ramji, D. P. (2008). Protein kinase CK2, and important regulator of the inflammatory response? Journal of Molecular Medicine, 86, 887-897.
61. Adenuga, D. and Rahman, I. (2010). Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes. Archives of Biochemistry and Biophysics, 498, 62-73.
62. Vogel, C. F., Nishimura, N., Sciullo, E., Wong, P., Li, W., and Matsumura, F. (2007). Modulation of the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Archives of Biochemistry and Biophysics, 461, 169-175.
63. Liu, P. C. and Matsumura, F. (2007). TCDD suppresses insulinresponsive glucose transporter (GLUT-4) gene expression through C/EBP nuclear transcription factors in 3T3-L1 adipocytes. Journal of Biochemical and Molecular Toxicology, 20, 79-87.
64. Vogel, C. F., Sciullo, E., Li, W., Wong, P., Lazennec, G., and Matsumura, F. (2007). RelB, a new partner of aryl hydrocarbon receptor-mediated transcription. Molecular Endocrinology, 21, 2941-2955.
65. Ohtake, F., Fujii-Kuriyama, Y., and Kato, S. (2009). AHR acts as an E3 ubiquitin ligase to modulate steroid receptor functions. Biochemical Pharmacology, 77, 474-484.
66. Gomez-Duran, A., Carvajal-Gonzalez, J. M., Mulero-Navarro, S., Santiago-Josefat, B., Puga, A., and Fernandez-Salguero, P. M. (2007). Fitting a xenobiotic receptor into cell homeostasis: how the dioxin receptor interacts with TGFb signaling. Biochemical Pharmacology, 77, 700-712.
67. Vogel, C. F. and Matsumura, F. (2009). A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kB family. Biochemical Pharmacology, 77, 734-745.
68. Vogel, C. F., Goth, S. R., Dong, B., Pessah, I. N., and Matsumura, F. (2008). Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochemical and Biophysical Research Communication, 375, 331-335.
69. Quintana, F. J., Basso, A. S., Iglesias, A. H., Korn, T., Farez, M. F., Bettelli, E., Caccamo, M., Oukka, M., and Weiner, H. L. (2008). Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor. Nature, 453, 65-71.
70. Dunlap, D. Y., Ikeda, I, Nagashima, H., Vogel, C. F., and Matsumura, F. (2002). Effects of src-deficiency on the expression of in vivo toxicity of TCDD in a strain of c-src knockout mice procured through six generations of backcrossings to C57BL/6 mice. Toxicology, 172, 125-141.
71. Vogel, C. F. and Matsumura, F. (2003). Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) with induced adipocyte differentiation in mouse embryonic fibroblasts (MEFs) involves tyrosine kinase c-Src. Biochemical Pharmacology, 66, 1231-1244.
72. Couture, L. A., Abbott, B. D., and Birnbaum L. S. (1990). A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. Teratology, 42, 619-627.
73. Moore, J. A., Gupta, B. N., Zinkl, J. G., and Vos, J. G. (1973). Postnatal effects of maternal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Environmental Health Perspectives, 5, 81-85.
74. Couture-Haws, L., Harris, M.W., McDonald, M. M., Lockhart, A. C., and Birnbaum, L. S. (1991). Hydronephrosis in mice exposed to TCDD-contaminated breast milk: identification of the peak period of sensitivity and assessment of potential recovery. Toxicology and Applied Pharmacology, 107, 413-428.
75. Nishimura, N, Matsumura, F., Vogel, C. F., Nishimura, H., Yonemoto, J., Yoshioka, W., and Tohyama, C. (2008). Critical role of cyclooxygenase-2 activation in pathogenesis of hydronephrosis caused by lactational exposure of mice to dioxin. Toxicology and Applied Pharmacology, 231, 374-383.
76. Seibert, K., Masferrer, J. L., Needleman, P., and Salvemini, D. (1996). Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney. British Journal of Pharmacology, 117, 1016-1020.
77. Yang, F. and Bleich, D. (2004). Transcriptional regulation of cyclooxygenase-2 gene in pancreatic beta-cells. Journal of Biological Chemistry, 279, 35403-35411.
78. Kinehara, M., Fukuda, I., Yoshida, K., and Ashida, H. (2009). Aryl hydrocarbon receptor-mediated induction of the cytosolic phospholipase A(2)alpha gene by 2,3,7,8-tetrachlorodibenzop-dioxin in mouse hepatoma Hepa-1c1c7 cells. Journal of Bioscience and Bioengineering, 108, 277-281.
79. Harris, S. L. and Levine, A. J. (2005). The p53 pathway: positive and negative feedback loops. Oncogene, 24, 2899-2908.
80. Shtil, A. A. and Azare, J. (2005). Redundancy of biological regulation as the basis of emergence of multidrug resistance. International Reviews on Cytology, 246, 1-29.
81. Kung, T., Murphy, K. A., and White, L. A. (2009). The aryl hydrocarbon receptor (AHR) pathway as a regulatory pathway for cell adhesion and matrix metabolism. Biochemical Pharmacology, 77, 536-546.
82. Vezina, C. M., Lin, T. M., and Peterson, R. E. (2009). AHR signaling in prostate growth, morphogenesis, and disease. Biochemical Pharmacology, 77, 566-576.
83. Hanneman,W. H., Legare, M. E., Barhoumi, R., Burghardt, R. C., Safe, S., and Tiffany-Castiglioni, E. (1996). Stimulation of calcium uptake in cultured rat hippocampal neurons by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology, 112, 19-28.
84. Ray, S. and Swanson, H. I. (2009). Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event? Biochemical Pharmacology, 77, 681-688.
85. Taylor, M. J., Lucier, G. W., Mahler, J. F., Thompson, M., Lockhart, A. C., and Clark, G. C. (1992). Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicology and Applied Pharmacology, 117, 126-132.
86. Takeda, K. (2005). Evolution and integration of innate immune recognition systems: the Toll-like receptors. Journal of Endotoxin Research, 11, 51-55.
87. Cullinan, S. B. and Diehl, J. A. (2006). Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. International Journal of Biochemistry and Cell Biology, 38, 317-332.
88. Ganey, P. E. and Roth, R. A. (2001). Concurrent inflammation as a determinant of susceptibility to toxicity from xenobiotic agents. Toxicology, 169, 195-208.
89. Roux, P. P. and Blenis, J. (2004).ERKand p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiology and Molecular Biology Reviews, 68, 320-344.
90. Esser, C. (2009). The immune phenotype of AHR null mouse mutants: not a simple mirror of xenobiotic receptor overactivation. Biochemical Pharmacology, 77, 597-607.
91. Kirkvliet N. I. (2009). AHR-mediated immunomodulation: the role of altered transcription. Biochemical Pharmacology, 77, 746-760.